Sonoma Pharmaceuticals (SNOA) Financials

$1.31

$-0.01 (-0.38%)

As on 11-Sep-2026 12:47EDT

Market cap

$6 Mln

Revenue (TTM)

$22 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Operating Revenue	21.92	19.53	14.29	12.74	13.27	12.63
Cost of Revenue	13.39	12.11	8.82	7.99	8.80	8.64
Gross Profit	8.53	7.42	5.47	4.75	4.48	3.99
Operating Expenses	9.93	9.88	9.18	9.45	9.05	9.88
Operating Profit (EBIT)	-1.41	-2.46	-3.71	-4.70	-4.57	-5.89
Other Income	--	--	--	--	--	--
Profit before Tax	-2.51	-3.42	-2.91	-5.03	-5.18	-5.42
Provision for Tax	-0.24	-0.24	0.55	-0.20	-0.03	-0.33
Profit after Tax (Net Income)	-2.26	-3.18	-3.46	-4.84	-5.15	-5.09
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-5.15	-5.09

Liabilities ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Shareholder's Funds	6.59	3.10	4.41	6.14	7.98	8.70
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.07	6.03	5.19	4.88	4.54	4.33
Current Liabilities	5.45	4.83	4.10	3.72	3.72	5.82
Total Liabilities	23.55	13.96	13.69	14.74	16.23	18.85

Assets ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Non-Current Assets	1.84	1.86	1.05	2.19	2.43	2.42
Current Assets	16.27	12.10	12.65	12.55	13.80	16.43
Total Assets	23.55	13.96	13.69	14.74	16.23	18.85
Total Debt*	0.74	0.84	0.31	0.61	0.85	1.37
Net Current Assets	10.82	7.27	8.55	8.83	10.08	10.61

Cashflow ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Cash From Operating Activities	--	-3.93	-0.09	-2.40	-6.15	-4.25
Cash Flow from Investing Activities	--	-0.19	-0.08	0.00	-0.26	-0.10
Cash from Financing Activities	--	0.48	3.03	1.68	2.49	7.40
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Adjusted EPS ($)	-1.22	-1.80	-2.79	-6.20	-11.01	-1.64
Cash EPS ($)	--	-1.72	-2.67	-5.97	-10.74	-1.58
Adjusted Book Value ($)	--	1.75	3.55	7.86	17.05	2.80
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.23	-0.07	-3.07	-13.15	-1.37
Free Cash Flow per Share ($)	--	-2.34	-0.14	-3.09	-13.73	-1.41

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
ROCE (%)	--	-73.38	-60.33	-62.10	-54.54	-56.19
ROE (%)	-45.16	-84.60	-65.55	-68.51	-61.78	-72.35
ROA (%)	-10.53	-22.96	-24.32	-31.22	-29.37	-30.07
EBIT Margin (%)	-6.23	-12.60	-20.35	-39.51	-39.06	-42.83
Net Margin (%)	-10.33	-16.26	-24.20	-37.97	-38.81	-40.28
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Revenue Growth (%)	47.00	0.37	0.12	-0.04	0.05	-0.32
EBIT Growth (%)	62.39	15.34	42.22	2.95	4.14	-56.80
Net Profit Growth (%)	36.32	8.16	28.50	6.13	-1.28	-28.76
EPS Growth (%)	53.26	0.35	0.55	0.44	-5.71	0.13
Book Value Growth (%)	-30.63	--	--	--	--	--

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Price / Earnings	--	-1.18	-0.79	-0.03	-0.09	-2.44
Price / Book Value	0.94	1.21	0.62	0.02	0.06	1.43
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	11.46	-0.95	0.85	0.49	0.50	-1.23
Close Price ($)	1.23	2.13	2.19	3.33	19.53	80.20
High Price ($)	6.92	6.92	9.37	30.40	85.00	267.20
Low Price ($)	0.85	1.75	1.90	2.40	18.00	51.00
Market Cap ($ Cr)	6.34	--	--	--	--	--

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debt to Equity	--	0.27	0.07	0.10	0.11	0.16
Short term debt to equity ratio	0.05	0.12	0.06	0.08	0.09	0.12
Current Ratio	2.99	2.50	3.09	3.37	3.71	2.82
Quick Ratio	2.29	1.75	2.38	2.64	2.94	2.37
Interest Coverage	--	--	--	--	-324.00	-540.80

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debtors to sales (%)	14.52	27.83	26.34	47.07	19.38	19.06
Asset Turnover	1.02	1.41	1.01	0.82	0.76	0.75
Receivable days	--	86.01	124.71	122.84	68.51	75.39
Inventory Days	--	98.99	116.62	127.47	114.64	109.83
Payable days	--	43.36	32.29	33.10	51.54	72.12
Cash Conversion Cycle	--	141.64	209.04	217.22	131.62	113.10

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.